PHI with Liver metastasis
How does this condition affect your private health insurance?
Lebermetastase, or liver metastasis, refers to cancer that has spread from its original site to the liver. It signifies advanced-stage disease and is a common complication of many cancers, particularly colorectal, breast, lung, and pancreatic cancers. The liver's rich blood supply makes it a frequent target for metastatic cells. Symptoms can include abdominal pain, weight loss, jaundice, and fatigue, often appearing late. Diagnosis typically involves imaging like CT or MRI scans. Treatment depends on the primary cancer, extent of spread, and overall patient health, often involving chemotherapy, targeted therapy, immunotherapy, surgery, or ablation, with the goal of prolonging life and improving quality of life.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months, depending on treatment intensity and response.
Duration of Illness (Lifetime)
Chronic, often managed over the remaining lifetime with ongoing therapies.
Cost of Treatment (Initial)
High (tens of thousands to hundreds of thousands USD), including diagnostics, surgery, chemotherapy, radiation, and targeted therapies.
Cost of Treatment (Lifetime)
Very high (hundreds of thousands to millions USD), with continuous management, repeat treatments, palliative care, and supportive therapies.
Mortality Rate
High (often 70-90% within 5 years, highly dependent on primary cancer and extent of metastasis), as it indicates advanced cancer.
Risk of Secondary Damages
Very high (>90%), including liver dysfunction, pain, fatigue, cachexia, jaundice, ascites, and severe side effects from aggressive systemic treatments.
Probability of Full Recovery
Low (<5%), complete eradication is rare; treatment often aims for disease control and palliation, not cure.
Underlying Disease Risk
100%, as liver metastasis is always secondary to a primary cancer (e.g., colorectal, breast, lung, pancreatic, gastric).